1315465-27-0 Usage
Molecular structure
Contains a bromo and a trifluoromethyl group attached to a phenoxy ring, as well as an amine group.
Usage
Commonly used in the pharmaceutical industry as a potential drug candidate.
Potential applications
Studied for its potential use in treating neurological disorders and cancer.
Research status
Further research is needed to fully understand its properties and potential applications.
Safety precautions
Proper handling and safety precautions are necessary when working with this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1315465-27-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,5,4,6 and 5 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1315465-27:
(9*1)+(8*3)+(7*1)+(6*5)+(5*4)+(4*6)+(3*5)+(2*2)+(1*7)=140
140 % 10 = 0
So 1315465-27-0 is a valid CAS Registry Number.
1315465-27-0Relevant academic research and scientific papers
1H-[1,2,3]TRIAZOLO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES
-
, (2011/08/04)
The invention relates to 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derived Cathepsin S inhibitors of Formula (I), wherein R1 is H or (C1-3)alkyl; R2 is halogen or (C1-4)alkyl, optionally substituted with one or more halogens; n is 1 -3; X is O or CH2; U, V and W are CH; or one of U, V and W is N; Y is a group capable of interacting with the Sn....S2 substites of the active site of Cathepsin S; or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S related diseases such as atherosclerosis, obesity, inflammation and immune disorders, such as rheumatoid arthritis, psoriasis, cancer, and chronic pain, such as neuropathic pain.
